Proposed model for the prediction of intrahepatic covalently closed circular DNA level in patients with chronic hepatitis B.

chronic hepatitis B hepatitis B core-related antigen hepatitis B surface antigen intrahepatic covalently closed circular DNA predictive model

Journal

Hepatology research : the official journal of the Japan Society of Hepatology
ISSN: 1386-6346
Titre abrégé: Hepatol Res
Pays: Netherlands
ID NLM: 9711801

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 06 09 2018
revised: 04 10 2018
accepted: 19 10 2018
pubmed: 26 10 2018
medline: 26 10 2018
entrez: 26 10 2018
Statut: ppublish

Résumé

We sought to create a prediction model for intrahepatic covalently closed circular DNA (IH-cccDNA) level in chronic hepatitis B (CHB) patients and to validate the model's predictive accuracy. Patients who did not receive previous nucleoside analogue (NA) therapy were assigned to the training cohort (n = 57), and those who received previous NA therapy were assigned to the validation cohort (n = 69). Factors linked to IH-cccDNA levels in the training cohort were analyzed and a formula to predict IH-cccDNA levels was constructed. Next, the reproducibility of that formula was assessed. In the multivariate analysis for the prediction of IH-cccDNA level in the training cohort, fasting blood sugar (FBS) (P = 0.0227), hepatitis B e antigen (HBeAg) (P = 0.0067) and log Our proposed model for the prediction of IH-cccDNA level could be helpful in CHB patients.

Identifiants

pubmed: 30358027
doi: 10.1111/hepr.13280
doi:

Types de publication

Journal Article

Langues

eng

Pagination

271-283

Subventions

Organisme : Japan Agency for Medical Research and Development
ID : 00101
Organisme : Japan Agency for Medical Research and Development
ID : 5532

Informations de copyright

© 2018 The Japan Society of Hepatology.

Auteurs

Kunihiro Hasegawa (K)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.

Hiroki Nishikawa (H)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.

Hirayuki Enomoto (H)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.

Yoshinori Iwata (Y)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.

Yoshiyuki Sakai (Y)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.

Naoto Ikeda (N)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.

Tomoyuki Takashima (T)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.

Nobuhiro Aizawa (N)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.

Ryo Takata (R)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.

Kazunori Yoh (K)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.

Noriko Ishii (N)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.

Yukihisa Yuri (Y)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.

Takashi Nishimura (T)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.

Hiroko Iijima (H)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.

Etsuro Hatano (E)

Division of Hepatobiliary and Pancreatic disease, Department of Surgery, Hyogo College of Medicine, Nishinomiya, Japan.

Jiro Fujimoto (J)

Division of Hepatobiliary and Pancreatic disease, Department of Surgery, Hyogo College of Medicine, Nishinomiya, Japan.

Shuhei Nishiguchi (S)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.

Classifications MeSH